NVDA 20-day bearish forecast — Nov 8, 2026

  • Bias: Bearish
  • Timeframe: 20 days (made Nov 8, 2026, target date Nov 27, 2026)
  • Price at analysis: $186.64
  • Price target: $181.50
  • Expected range: $172.00 – $193.00
  • Result: Pending — graded after the close on Nov 27, 2026

Get a free AI analysis of NVDA today

NVDA technical analysis chart

Analysis

TECHNICAL INDICATORS

  • RSI (14): 30.76, bouncing off 25.4 on Nov 5, which was deeply oversold. It is still at the edge of oversold and well below 50, so momentum is weak. A relief bounce is possible, but there is no bullish RSI structure yet. [Bearish]
  • 20 EMA (EMA 21): $209.28, with price about 10.8% below it. The EMA is falling steeply (from $224.76 on Oct 19) and acts as overhead resistance. EMA21 also crossed below EMA55 ($215.22) around Oct 29, a bearish crossover. [Bearish]
  • MACD: Line -8.24 is below Signal -5.04, a bearish crossover that happened around Oct 23. The gap is widening (histogram about -3.2 and falling), and the line is accelerating lower. [Bearish]
  • Bollinger Bands (20): Bands are $188.34 to $234.76. Price at $186.64 is below the lower band after a volatility expansion and a sharp band-walk down. This is stretched and can trigger a bounce, but in a strong trend a close below the lower band often signals continuation. [Bearish]
  • CMF (20): -0.335, well below -0.05 and the lowest in the recent series (it was -0.14 on Oct 30). Sustained, worsening distribution. [Distribution]
  • ADX (14): 28.9 and rising (17.4 on Oct 19), with −DI 41.6 far above +DI 9.9. This is a strong downtrend with sellers firmly in control. +DI is near its low for the period. [Strong Trend – Bearish]
  • Volume: 179.72M, among the highest bars on the chart. The Nov 5 breakdown candle came on the heaviest volume of the period. That is heavy selling, with possible capitulation characteristics. It confirms the breakdown, but a stabilizing reversal would need follow-through. [Bearish – high-volume distribution]

Other trend context:

  • Price is below the SMA200D ($204.67), the SMA50D ($219.81), VWAP ($214.55), and both EMAs. This is a full bearish stack.
  • The SMA50D is still above the SMA200D, so there is no death cross yet. The gap has narrowed to about $15 and is closing.

DIVERGENCES & TRENDS

  • No bullish divergence yet: Price made a new low at $181.60, and RSI (25.4) and MACD both made lower lows with it. Indicators confirm the price weakness.
  • Momentum: The MACD line fell from -0.79 to -8.24 in 15 bars, and the histogram is widening negative. Momentum is accelerating down, not fading.
  • Trend strength: ADX rose from 17 to 29 with −DI dominant, so a trend is emerging out of a prior range.
  • Money flow: CMF has moved from the neutral/slightly negative zone to -0.335, confirming distribution.
  • Key breaks:
  • EMA21 crossed below EMA55 (about Oct 29).
  • MACD crossed below its signal (about Oct 23).
  • Price broke below the SMA200D (about Oct 30–Nov 5), a major support loss.
  • Price closed below the lower Bollinger Band.
  • Counter-signal: The long lower wick and Nov 6 bounce (+2.8%) with RSI recovering from 25 hint at an oversold relief rally. This is a tactical risk to the bearish view.

CHART PATTERNS

  • Broad top and breakdown: Price peaked near $240 in early October, then rolled over in a series of lower highs, consistent with a distribution/reversal top. The loss of the SMA200D resembles a Bearish Head and Shoulders / Double Top neckline breakdown, although it is not a textbook match.
  • Bearish Flag/Pennant-style continuation: The tight consolidation around $210–$220 from mid-to-late October ended in a sharp downside break. This resembles the Bearish Pennant/Flag continuation. The measured move from the flagpole implies further downside.
  • Targets: The initial gap is $181.60 (Nov 5 close/low area), then the ~$177.83 chart low. A break below that opens the room toward the mid-$170s. The upside is capped by the $200–$205 zone (SMA200D, now resistance).

POTENTIAL SCENARIOS

  • Scenario 1: Bearish Trend Continuation — The strong downtrend (ADX 29, −DI 41.6, CMF -0.335) persists, and any bounce fades below the EMA21/SMA200D. Price retests and probes below the Nov 5 low. Trigger: failure to hold $186–$188 or a daily close below $181.60. Target: $177–$182, with an extension to about $172. Invalidation: daily close above $200 (reclaiming the Nov 4 close and approaching the SMA200D). (50% probability)
  • Scenario 2: Bullish Oversold Relief Rally — Capitulation-style volume and RSI at 25 trigger a mean-reversion bounce toward the declining EMA21 and the SMA200D. Trigger: a close above $192 with RSI above 40 and a MACD histogram that stops falling. Target: $195–$205 (the gap fill), where sellers should re-emerge. Invalidation: a close below $181.60 that negates the bounce. (33% probability)
  • Scenario 3: Neutral Basing Range — Price stabilizes after the shock and chops between the Nov 5 low and lower-band resistance for most of the period. Trigger: low-volume, narrow-range candles with ADX flattening. Target: $182–$194. Invalidation: a break outside this range on volume. (17% probability)

PRICE TARGETS

  • Target Price: $181.50 (20-day, about 2.8% below current)
  • Expected Range: $172.00 to $193.00 (width $21.00, about 11.3% of current price, consistent with the 14–21 day guidance)
  • Key Levels: Support at $181.60 (Nov 5 close/low zone, with the chart low near $177.83 below it), Resistance at $200.13 (Nov 4 close, just below the $204.67 SMA200D)

OVERALL BIAS

OVERALL BIAS: BEARISH – Price broke below the SMA200D and the lower Bollinger Band on heavy volume. ADX is rising with −DI dominant, MACD is accelerating lower, CMF shows heavy distribution, and all major moving averages are overhead. The oversold RSI makes a relief bounce likely along the way, but the dominant evidence favors continued weakness over the 20 days.

This is educational analysis and not financial advice.

More NVDA predictions

See every NVDA prediction and its track record

Get a free AI analysis of NVDA today

AI-generated technical analysis for education only — not financial advice.